Arcturus Therapeutics Holdings Inc. · NASDAQ:ARCT
Sumitomo Mitsui Trust Group, Inc. reported a 7.20% stake in Arcturus Therapeutics Holdings Inc. (Schedule 13G/A)
Event Sep 30, 2025 · Filed Oct 27, 2025
Sumitomo Mitsui Trust Group, Inc. reported a 7.20% stake in Arcturus Therapeutics Holdings Inc., 1,947,835 shares, as a passive investor on Sep 30, 2025. Filed Oct 27, 2025 (Schedule 13G/A).
- Stake
- 7.20%
- Shares
- 1,947,835
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Sumitomo Mitsui Trust Group, Inc. | 7.20% | 1,947,835 |
| Amova Asset Management Co., Ltd. | 7.20% | 1,947,835 |
Source
Related
- Arcturus Therapeutics Holdings Inc.
- Sumitomo Mitsui Trust Group, Inc.
- Arcturus Therapeutics Holdings Inc. shareholders
- Schedule 13G/A · Sumitomo Mitsui Trust Group, Inc. · Apr 25, 2025
- Schedule 13G/A · Federated Hermes, Inc. · Oct 7, 2026
- Schedule 13G/A · ARK Investment Management LLC · May 7, 2026
- Schedule 13G/A · The Vanguard Group · Mar 26, 2026
- Schedule 13G/A · Balyasny Asset Management L.P. · Feb 17, 2026
- Schedule 13G/A · ARK Investment Management LLC · Feb 3, 2026